You are here
- News and Events
- Hinacom Licenses 3-D Lesion Segmentation Software from Columbia
Hinacom Licenses 3-D Lesion Segmentation Software from Columbia
Originally posted by Hinacom, April 2014
Hinacom Software and Technology Ltd (hereafter Hinacom) and Columbia University (hereafter CU) have signed a licensing agreement for novel imaging software that facilitates lung lesion quantification via advanced 3-D segmentation, the process by which abnormal anatomical structures in medical images are automatically detected and quantified.
"Efficient and accurate quantification of lung lesions and their changes over time using advanced segmentation algorithm will facilitate better diagnosis of disease and response assessment,” said Lawrence Schwartz, MD, professor and chair of the Department of Radiology, Columbia University Medical Center, who has extensive experience in both conventional and novel imaging techniques. “Our algorithms have been developed in response to the growing demand for quantitative imaging techniques that provide fast and more accurate tumor delineation. At the Computational Image Analysis Laboratory, led by Binsheng Zhao, DSc, professor of clinical radiology, we have incorporated advanced image analysis methodologies to address these needs. Columbia is pleased to have established a relationship with Hinacom, a healthcare IT solutions and service provider.”
Three-D segmentation of CT and MR images provides a reliable way to identify lesions in chest and abdominal organs. Traditionally, these algorithms and related analysis tools were only available on localized workstations. The migration of these analysis tools to a cloud-based architecture will enable rapid dissemination of such advanced technology to a much broader user base.
"We are excited to have reached an agreement with Columbia University ,” said Tony Cui, CEO at Hinacom, “The licensed software will be integrated into Hinacom’s miPlatform Medical Imaging Suite, which is an integrated software platform offering PACS, RIS, tele-radiology, tele-consultation and 3D medical image analysis, and post processing capabilities. It is cloud-based and accessible via web and mobile. Lung tumors are becoming more prevalent and we hope that our collaborative efforts will lead to improved patient care by providing state of the art analysis tools to physician users anytime, anywhere, to facilitate earlier and more accurate tumor diagnosis and treatment planning.”
About Columbia Technology Ventures
Columbia University's technology transfer office, Columbia Technology Ventures, manages Columbia's intellectual property portfolio and serves as the university's gateway for companies and entrepreneurs seeking novel technology solutions. Our core mission is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national and global basis. For more information on Columbia Technology Ventures, please visit www.techventures.columbia.edu.
Hinacom Software and Technology, Ltd. (hereafter Hinacom) is a leading Healthcare IT solution and services provider located in Beijing, China. It was established in 2008 by industry veterans with a combined 50+ years of global healthcare IT and medical imaging experience. Hinacom has developed world leading medical imaging and information system solutions that are used in over hundreds of clinical sites in China, US and SE Asia. Hinacom is recognized as a National High Tech Company and a Tsinghua Science Park “Diamond Enterprise” for its innovative technology, products and customer recognitions. Hinacom is partially funded by world renowned Venture Capital firm Sequoia Capital. For more information, visit www.hinacom.com.